Immunotherapy combined with antiangiogenic therapy as third‐ or further‐line therapy for stage IV non‐small cell lung cancer patients with ECOG performance status 2: A retrospectiv... oleh Shuo Li, Ze‐Shun Yu, Hong‐Zhi Liu, Shu‐Jing Li, Ming‐Yue Wang, Fang‐Ling Ning, Li‐Jun Tian